Swedish companies producing specialized pharmaceuticals

Firms in this secondary pharmaceutical group focus on niche therapeutics, animal health products, or specialized clinical compounds. Specific patent rulings and localized regulatory approvals inject sudden volatility into these stocks. Right now, Hemply Balance Holding AB commands the highest trading volume, and New Nordic Healthbrands AB captures the greatest 24-hour price growth. You can find more fundamental and technical metrics in the table below.
Symbol
Mkt cap
Price
Chg %
Vol
Rel vol
P/E
EPS dil
TTM
EPS dil growth
TTM YoY
Div yield %
TTM
Sector
Analyst rating
BIOG_BBioGaia AB Class B
12.33 B SEK122.1 SEK+1.24%85.95 K0.3131.553.87 SEK+23.94%1.35%Health technology
Buy
MSON_AMidsona AB Class A
1.37 B SEK13.0 SEK0.00%2800.7411.401.14 SEK—1.69%Health technology
No rating
MSON_BMidsona AB Class B
1.37 B SEK9.20 SEK−0.22%118.13 K0.808.061.14 SEK—2.34%Health technology
No rating
NNHNew Nordic Healthbrands AB
92.62 M SEK15.00 SEK+2.39%1.32 K0.1020.510.73 SEK−43.94%1.67%Health technology
No rating
HMPLYHemply Balance Holding AB
10.98 M SEK0.0680 SEK−8.11%388.78 K0.56—−0.00 SEK+6.45%0.00%Health technology
No rating